CA3147218A1 - Forme posologique d'infusion de norepinephrine - Google Patents

Forme posologique d'infusion de norepinephrine Download PDF

Info

Publication number
CA3147218A1
CA3147218A1 CA3147218A CA3147218A CA3147218A1 CA 3147218 A1 CA3147218 A1 CA 3147218A1 CA 3147218 A CA3147218 A CA 3147218A CA 3147218 A CA3147218 A CA 3147218A CA 3147218 A1 CA3147218 A1 CA 3147218A1
Authority
CA
Canada
Prior art keywords
dosage form
norepinephrine
ready
infuse
microgram
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3147218A
Other languages
English (en)
Inventor
Samarth Kumar
Maheshkumar Parasmal Soni
Praveen Kumar SRIVASTAVA
Prashant Kane
Subhas Balaram Bhowmick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharmaceutical Industries Ltd
Original Assignee
Samarth Kumar
Sun Pharmaceutical Industries Limited
Maheshkumar Parasmal Soni
Praveen Kumar SRIVASTAVA
Prashant Kane
Subhas Balaram Bhowmick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samarth Kumar, Sun Pharmaceutical Industries Limited, Maheshkumar Parasmal Soni, Praveen Kumar SRIVASTAVA, Prashant Kane, Subhas Balaram Bhowmick filed Critical Samarth Kumar
Publication of CA3147218A1 publication Critical patent/CA3147218A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La présente invention concerne une forme posologique aqueuse stable prête à l'emploi de norépinéphrine comprenant une solution aqueuse de norépinéphrine ou son sel pharmaceutiquement acceptable, un ou plusieurs antioxydants de sulfite et un chélateur d'ions. La présente invention concerne également un récipient de perfusion rempli d'une solution aqueuse de norépinéphrine ou de son sel pharmaceutiquement acceptable, ladite solution étant stable pendant une période de temps prolongée et pouvant être stérilisée de manière terminale par autoclavage.
CA3147218A 2019-08-08 2020-08-10 Forme posologique d'infusion de norepinephrine Pending CA3147218A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201921032096 2019-08-08
IN201921032096 2019-08-08
PCT/IB2020/057517 WO2021024237A1 (fr) 2019-08-08 2020-08-10 Forme posologique d'infusion de norépinéphrine

Publications (1)

Publication Number Publication Date
CA3147218A1 true CA3147218A1 (fr) 2021-02-11

Family

ID=72088340

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3147218A Pending CA3147218A1 (fr) 2019-08-08 2020-08-10 Forme posologique d'infusion de norepinephrine

Country Status (6)

Country Link
US (3) US11197838B2 (fr)
EP (1) EP4009943A1 (fr)
CN (1) CN114286669A (fr)
AU (1) AU2020325831A1 (fr)
CA (1) CA3147218A1 (fr)
WO (1) WO2021024237A1 (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7243689B2 (en) 2000-02-11 2007-07-17 Medical Instill Technologies, Inc. Device with needle penetrable and laser resealable portion and related method
CN101001782A (zh) 2002-09-03 2007-07-18 因斯蒂尔医学技术有限公司 密封容器和用于制作和填充该容器的方法
US8628805B2 (en) * 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound
MX2011012735A (es) * 2009-06-04 2012-02-28 Alk Ag Composicion estabilizada que comprende por lo menos un compuesto adrenergico.
ES2770731T3 (es) * 2014-08-28 2020-07-02 Sun Pharmaceutical Ind Ltd Forma de dosificación parenteral de norepinefrina
US9119876B1 (en) * 2015-03-13 2015-09-01 Par Pharmaceutical, Inc. Epinephrine formulations

Also Published As

Publication number Publication date
CN114286669A (zh) 2022-04-05
WO2021024237A1 (fr) 2021-02-11
US11865089B2 (en) 2024-01-09
AU2020325831A1 (en) 2022-03-03
US20220054434A1 (en) 2022-02-24
EP4009943A1 (fr) 2022-06-15
US11197838B2 (en) 2021-12-14
US20240115523A1 (en) 2024-04-11
US20210038539A1 (en) 2021-02-11

Similar Documents

Publication Publication Date Title
JP6812094B2 (ja) ノルエピネフリンの注射剤形
US11413259B2 (en) Norepinephrine compositions and methods therefor
JP3021312B2 (ja) プラノプロフェンの安定化方法および安定なプラノプロフェン水性液剤
EA008308B1 (ru) Жидкие стабилизированные белковые составы в фармацевтических контейнерах с покрытием
EP2666463A1 (fr) Composition liquide stabilisée comprenant du pemetrexed
WO2020021567A1 (fr) Dispositif d'injection de fentanyl
US20230181495A1 (en) Packaged, sealed container system for stable storage of an oxygen sensitive pharmaceutical formulation
US11197838B2 (en) Infusion dosage form of norepinephrine
WO2005077376A1 (fr) Preparation parenterale stable comprenant de la levomepromazine et methode de stabilisation de ladite preparation
WO2023072714A1 (fr) Phytonadione pour administration parentérale
US20230321005A1 (en) Phytonadione compositions
US11806320B2 (en) Isoproterenol compositions and methods
CA2442365A1 (fr) Solution parenterale premelangee a base d'amiodarone et son procede de fabrication
US11786512B2 (en) Stable pharmaceutical compositions of dihydroergotamine mesylate
US9757352B2 (en) Parenteral dosage form of amiodarone
US20220233473A1 (en) Injectable solution of norepinephrine
WO2022058988A1 (fr) Forme galénique parentérale de diltiazem